Bringing the fundamentals into focus…
Back to Larimar Therapeutics, Inc.
How Larimar Therapeutics, Inc. stacks up
LRMR · against 327 other Healthcare companies of similar size
Profitability
8/ 100
Near the bottom of its peers.
Ranked #291 of 328 · scores higher than 9% of peers
Bars: peers in each 10-point band of the profitability score43 peers with a profitability score of 0–9, including LRMR · Click a bar to see the companies
Why profitability scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 98% of peers. Return on assets: -104.4% vs peer median 1.7%
- a lower return on invested capital: weaker than 97% of peers. Return on invested capital: -407.5% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = LRMR, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | LRMR | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 290 reported | -407.5% | -0.5% | 3% | 33% | |
| Operating marginHigher is better · 307 reported | Not reported | 2.1% | — | — | 33% |
| Return on assetsHigher is better · 328 reported | -104.4% | -0.4% | 2% | 33% | |
| Return on equityHigher is better · 307 reported | -139.6% | -0.7% | 4% | Context only | |
| Gross marginHigher is better · 344 reported | 0.0% | 37.3% | 6% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around LRMR| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 433M USD | 99 | 81 | |
| 2 | 5.5B NOK (≈$523M) | 98 | 71 | |
| 2 | 261M USD | 98 | 97 | |
| 4 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 4 | 356M AUD (≈$235M) | 97 | 81 | |
| 286 | 468M USD | 9 | 40 | |
| 291 | 243M USD | 8 | 27 | |
| 291 | 357M USD | 8 | 32 | |
| 291 | 172M USD | 8 | 41 | |
| 291 | 264M USD | 8 | 30 | |
| 291 | 332M USD | 8 | 35 | |
| 291 | 334M USD | 8 | 49 | |
| 291 | 303M USD | 8 | 27 | |
| 298 | 271M USD | 7 | 14 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score